Total Payments
$493,882
2024 Payments
$56,396
Companies
59
Transactions
1,068
Medicare Patients
29,730
Medicare Billing
$7.2M
Payment Breakdown by Category
Other$357,438 (72.4%)
Travel$65,758 (13.3%)
Consulting$49,609 (10.0%)
Food & Beverage$20,515 (4.2%)
Education$561.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $344,558 | 162 | 69.8% |
| Travel and Lodging | $65,758 | 188 | 13.3% |
| Consulting Fee | $49,609 | 18 | 10.0% |
| Food and Beverage | $20,515 | 687 | 4.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,800 | 2 | 1.8% |
| Honoraria | $4,080 | 1 | 0.8% |
| Education | $561.93 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $137,652 | 273 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $110,184 | 105 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $95,285 | 117 | $0 (2024) |
| PFIZER INC. | $55,344 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $49,889 | 138 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $19,019 | 28 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $11,117 | 12 | $0 (2017) |
| UROGEN PHARMA, INC. | $5,206 | 19 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,924 | 3 | $0 (2024) |
| Exelixis Inc. | $1,470 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,396 | 125 | Astellas Pharma US Inc ($28,103) |
| 2023 | $95,254 | 157 | Dendreon Pharmaceuticals LLC ($40,762) |
| 2022 | $101,255 | 158 | Astellas Pharma US Inc ($42,367) |
| 2021 | $45,764 | 116 | Bayer HealthCare Pharmaceuticals Inc. ($30,511) |
| 2020 | $39,610 | 92 | Dendreon Pharmaceuticals LLC ($20,396) |
| 2019 | $67,197 | 158 | PFIZER INC. ($26,598) |
| 2018 | $54,617 | 150 | PFIZER INC. ($22,286) |
| 2017 | $33,788 | 112 | Astellas Pharma US Inc ($21,781) |
All Payment Transactions
1,068 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: HORMONE THERAPY | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,902.00 | General |
| Category: Oncology | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $104.67 | General |
| Category: Oncology | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Oncology | ||||||
| 11/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $178.02 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Oncology | ||||||
| 11/13/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Oncology | ||||||
| 11/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $307.77 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $425.00 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Oncology | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Diagnostic Imaging | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $151.40 | General |
| Category: OS | ||||||
| 10/21/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 58 | 8,295 | 82,374 | $3.2M | $886,807 |
| 2022 | 46 | 7,469 | 82,228 | $5.4M | $2.3M |
| 2021 | 49 | 7,354 | 86,355 | $5.1M | $2.1M |
| 2020 | 48 | 6,612 | 54,859 | $4.9M | $1.9M |
Total Patients
29,730
Total Services
305,816
Medicare Billing
$7.2M
Procedure Codes
201
All Medicare Procedures & Services
201 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 51 | 16,380 | $655,200 | $304,060 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,133 | 2,010 | $382,010 | $170,074 | 44.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 92 | 888 | $799,200 | $119,266 | 14.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 783 | 1,695 | $127,125 | $30,415 | 23.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 232 | 896 | $125,440 | $22,588 | 18.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 145 | 383 | $57,450 | $17,946 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 163 | 163 | $48,900 | $16,724 | 34.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 863 | 1,849 | $36,980 | $15,516 | 42.0% |
| 87900 | Infectious agent drug susceptibility analysis | Office | 2023 | 97 | 115 | $37,490 | $14,690 | 39.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 74 | 75 | $102,750 | $13,386 | 13.0% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 91 | 232 | $33,640 | $10,500 | 31.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 29 | 32 | $124,400 | $10,055 | 8.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 137 | 161 | $80,500 | $9,118 | 11.3% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 15 | 15 | $72,680 | $8,781 | 12.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 1,083 | 1,686 | $33,720 | $8,503 | 25.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 91 | 95 | $62,700 | $7,206 | 11.5% |
| 49505 | Repair of groin hernia (5 years or older) | Facility | 2023 | 17 | 18 | $16,500 | $7,060 | 42.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 108 | 197 | $22,655 | $7,021 | 31.0% |
| 87482 | Detection test for candida species (yeast), quantification | Office | 2023 | 98 | 116 | $16,124 | $6,337 | 39.3% |
| 87492 | Detection test by nucleic acid for chlamydia trachomatis, quantification | Office | 2023 | 98 | 116 | $15,544 | $6,078 | 39.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 12 | 14 | $32,200 | $5,789 | 18.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 1,085 | 1,689 | $23,646 | $5,215 | 22.1% |
| 87592 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification | Office | 2023 | 98 | 116 | $12,412 | $4,870 | 39.2% |
| 87799 | Detection test by nucleic acid for organism, quantification | Office | 2023 | 97 | 115 | $12,305 | $4,828 | 39.2% |
| 87652 | Detection test by nucleic acid for strep (streptococcus, group a), quantification | Office | 2023 | 98 | 116 | $12,064 | $4,747 | 39.3% |
About Dr. Paul Eber, M.D
Dr. Paul Eber, M.D is a Urology healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124085634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Eber, M.D has received a total of $493,882 in payments from pharmaceutical and medical device companies, with $56,396 received in 2024. These payments were reported across 1,068 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($344,558).
As a Medicare-enrolled provider, Eber has provided services to 29,730 Medicare beneficiaries, totaling 305,816 services with total Medicare billing of $7.2M. Data is available for 4 years (2020–2023), covering 201 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Germantown, TN
- Active Since 04/27/2006
- Last Updated 09/13/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1124085634
Products in Payments
- PROVENGE (Drug) $121,301
- Xtandi (Drug) $95,120
- Nubeqa (Drug) $75,554
- XTANDI (Drug) $73,827
- Erleada (Drug) $28,872
- ERLEADA (Drug) $22,218
- Xofigo (Drug) $19,731
- LYNPARZA (Drug) $19,019
- SUTENT (Drug) $10,279
- JELMYTO (Drug) $4,931
- ORGOVYX (Drug) $4,820
- CABOMETYX (Drug) $1,470
- ZYTIGA (Drug) $587.06
- Myrbetriq (Drug) $436.51
- MYRBETRIQ (Drug) $405.80
- INTERSTIM (Device) $359.34
- KEYTRUDA (Biological) $353.53
- Prolia (Biological) $341.49
- Axumin (Drug) $331.69
- POSLUMA (Drug) $252.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Germantown
Michael Granieri, M.d, M.D
Urology — Payments: $134,363
Urology $134,363
Ravi Chauhan, M.d, M.D
Urology — Payments: $71,717
Urology $71,717
Dr. Adam Stewart, M.d, M.D
Urology — Payments: $55,364
Urology $55,364
John Adams, M.d, M.D
Urology — Payments: $21,785
Urology $21,785
Dr. William Shappley, M.d, M.D
Urology — Payments: $17,348
Urology $17,348
Zachary Corr, M.d, M.D
Urology — Payments: $12,281
Urology $12,281